Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib
- 1 May 2021
- journal article
- letter
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 147 (5) , 1795-1809
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Dermatology Foundation
This publication has 36 references indexed in Scilit:
- Autocrine IFN-γ Promotes Naive CD8 T Cell Differentiation and Synergizes with IFN-α To Stimulate Strong FunctionThe Journal of Immunology, 2012
- Interstitial fluid: the overlooked component of the tumor microenvironment?Fibrogenesis & Tissue Repair, 2010
- Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptorNature Immunology, 2009
- Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitorsScandinavian Journal of Rheumatology, 2009
- Histological and immunohistochemical study of granuloma annulare and subcutaneous granuloma annulare in childrenJournal of Cutaneous Pathology, 2006
- Histocompatibility antigens in granuloma annulareBritish Journal of Dermatology, 2006
- Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout miceHepatology, 2004
- T-Cell Receptor Repertoire and Cytokine Pattern in Granuloma Annulare: Defining a Particular Type of Cutaneous Granulomatous InflammationJournal of Investigative Dermatology, 2002
- Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survivalJournal of Clinical Investigation, 2001
- Increased plasma fibronectin in diabetes mellitus, necrobiosis lipoidica and widespread granuloma annulareClinical and Experimental Dermatology, 1984